Determination of the endotoxin aggression etiology as a prospect for improving the effectiveness of the treatment-and-prophylactic process

Author:

Rascheskov Arsenii A.ORCID,Markelova Marina M.ORCID,Anikhovskaya Irina A.ORCID,Beloglazov Vladimir A.ORCID,Gordienko Andrey I.ORCID,Meshkov Mikhail V.ORCID,Rascheskov Alexander Yu.ORCID,Tumanova Elena L.ORCID,Yakovlev Mikhail Yu.ORCID

Abstract

A third of a century ago, an assumption about the ability of intestinal microflora and stress to induce systemic inflammation, contrary to the fundamental postulates of general pathology, was made. Verification of this very bold assumption for that period of time, required the creation of a new methodological basis for studying the role of intestinal endotoxin (lipopolysaccharide) in human biology, which was successfully carried out by Russian scientists. The use of therapeutic agents to normalize the integral indicators of systemic endotoxinemia in the treatment regimen of a wide variety of diseases, including enterosorbents, choleretics, LPS filters, immune drugs, and other medications and procedures, has significantly increased the effectiveness of the treatment. The validity of the endotoxin theory of human physiology and pathology was also confirmed by the Nobel achievements of foreign colleagues (nomination 2008, prize 2011). They discovered the receptors of innate immunity, which made it possible to qualify LPS as an exohormone of adaptation, since TLR4 is the central receptor for regulating the activity level of the immune and other adaptive systems of the body. One of the reasons for the increase in the LPS concentration in the general bloodstream (what leads to the induction of systemic inflammation) may be the overgrowth of certain gram-negative bacteria that are part of the intestinal microbiota. Verification of these bacteria was first carried out by Ruaasian scientists and it is presented in this review. Determinating of the etiology of endotoxin aggression is a basic element in creating a new direction in nutrition and pharmaceuticals. The search for selective inhibition methods of excessive bacterial growth and the creation of medicines, food supplements and/or an individual diets based on them in the future is an important scientific task, the solution of which can significantly increase the effectiveness of treatment-and-prophylactic process and optimize material costs in the healthcare system.

Publisher

ECO-Vector LLC

Subject

General Medicine

Reference43 articles.

1. Role of intestinal microflora and insufficient barrier function of the liver in the development of endotoxinemia and inflammation

2. A brief history of studying the role of intestinal factor in aging and/or induction of systemic inflammation: Achievements, challenges, and prospects

3. Yakovlev MYu. Sistemnaya endotoksinemiya: gomeostaz i obshchaya patologiya. (Systemic endotoxinemia: homeostasis and general pathology.) Moscow: Nauka; 2021. 184 р. (In Russ.)

4. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

5. Medzhitov R, Dzhanevey CA Jr. Congenital immunity. Kazan Medical Journal. 2004;(3):161–167. (In Russ.)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3